Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors

出版年份 2017 全文链接

标题

作者

关键词

Chronic myeloid leukemia (CML), Tyrosine kinase inhibitor (TKI), BCR-ABL1, Treatment-free remission (TFR), Drug resistance, Mutation

出版物

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Volume 31, Issue 4, Pages 589-612

出版商

Elsevier BV

发表日期

2017-07-01

DOI

10.1016/j.hoc.2017.04.007

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More